{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:03:59Z","timestamp":1787321039334,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.xkme.2023.100645","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T06:26:16Z","timestamp":1681971976000},"page":"100645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Gut-Peritoneum Axis in Peritoneal Dialysis and\u00a0Peritoneal Fibrosis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1070-3602","authenticated-orcid":false,"given":"Natalia","family":"Stepanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/biom10050768","article-title":"Unfavorable effects of peritoneal dialysis solutions on the peritoneal membrane: the role of oxidative stress","volume":"10","author":"Roumeliotis","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.xkme.2023.100645_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/484167","article-title":"Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells","volume":"2012","author":"Yung","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/0896860820982218","article-title":"ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention","volume":"41","author":"Morelle","year":"2021","journal-title":"Perit Dial Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib4","doi-asserted-by":"crossref","first-page":"F999","DOI":"10.1152\/ajprenal.00012.2016","article-title":"Peritoneal dialysis: from bench to bedside and bedside to bench","volume":"311","author":"Perl","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.xkme.2023.100645_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109778","article-title":"Molecular pathways in peritoneal fibrosis","volume":"75","author":"Balzer","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.xkme.2023.100645_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.607204","article-title":"Mechanisms of peritoneal fibrosis: focus on immune cells\u2013peritoneal stroma interactions","volume":"12","author":"Terri","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2023.100645_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3543678","article-title":"Molecular mechanisms underlying peritoneal EMT and fibrosis","volume":"2016","author":"Strippoli","year":"2016","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.xkme.2023.100645_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Zhou","year":"2016","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib9","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2016.09.005","article-title":"Mesothelial cells and peritoneal homeostasis","volume":"106","author":"Mutsaers","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xkme.2023.100645_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/473134","article-title":"Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis","volume":"2014","author":"L\u00f3pez-Cabrera","year":"2014","journal-title":"Adv Med"},{"key":"10.1016\/j.xkme.2023.100645_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac011","article-title":"Epithelial\u2013mesenchymal transition in organ fibrosis development: current understanding and treatment strategies","volume":"10","author":"Liu","year":"2022","journal-title":"Burns Trauma"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib12","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1038\/s41598-020-63258-3","article-title":"Longitudinal changes of NF-\u03baB downstream mediators and peritoneal transport characteristics in incident peritoneal dialysis patients","volume":"10","author":"Fung","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-018-0710-z","article-title":"Matrix stiffness: the conductor of organ fibrosis","volume":"20","author":"Santos","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.xkme.2023.100645_bib14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1681\/ASN.2021010080","article-title":"Acquired decline in ultrafiltration in peritoneal dialysis: the role of glucose","volume":"32","author":"Krediet","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100645_bib15","first-page":"60","article-title":"Chronic kidney disease and fibrosis: the role of uremic retention solutes","volume":"2","author":"Mutsaers","year":"2015","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.xkme.2023.100645_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100645_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2215\/CJN.03630807","article-title":"Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology","volume":"3","author":"Honda","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100645_bib18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1681\/ASN.V12102146","article-title":"Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum","volume":"12","author":"Combet","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib19","article-title":"Hepatic microbiome in healthy lean and obese humans","volume":"3","author":"Suppli","year":"2021","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2215\/CJN.12161018","article-title":"Blood microbiome profile in CKD: a pilot study","volume":"14","author":"Shah","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100645_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.707515","article-title":"Microbiome in blood samples from the general population recruited in the MARK-AGE project: a pilot study","volume":"12","author":"D\u2019Aquila","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.xkme.2023.100645_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fsysb.2022.951403","article-title":"A\u00a0complete guide to human microbiomes: body niches, transmission, development, dysbiosis, and restoration","volume":"2","author":"Reynoso-Garc\u00eda","year":"2022","journal-title":"Front Syst Biol"},{"issue":"Pt 2","key":"10.1016\/j.xkme.2023.100645_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1099\/ijs.0.054171-0","article-title":"Integrating genomics into the taxonomy and systematics of the Bacteria and Archaea","volume":"64","author":"Chun","year":"2014","journal-title":"Int J Syst Evol Microbiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00053-19","article-title":"Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory","volume":"33","author":"Church","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? a changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.xkme.2023.100645_bib27","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The human gut microbiome\u2014a potential controller of wellness and disease","volume":"9","author":"Kho","year":"2018","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.xkme.2023.100645_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.23876\/j.krcp.21.053","article-title":"Intestinal microbiota and kidney diseases","volume":"40","author":"Kim","year":"2021","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.xkme.2023.100645_bib30","article-title":"The human microbiome in chronic kidney disease: a double-edged sword","volume":"8","author":"Wehedy","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.xkme.2023.100645_bib31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","article-title":"The gut microbiota and its relationship with chronic kidney disease","volume":"51","author":"Plata","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/0886022X.2020.1864404","article-title":"Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren Fail"},{"issue":"2","key":"10.1016\/j.xkme.2023.100645_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/nu14020352","article-title":"Gut microbiome and organ fibrosis","volume":"14","author":"Costa","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.xkme.2023.100645_bib34","article-title":"Uremic toxins in organ crosstalk","volume":"8","author":"Lowenstein","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.xkme.2023.100645_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/toxins12090590","article-title":"Gut-derived protein-bound uremic toxins","volume":"12","author":"Graboski","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.xkme.2023.100645_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100645_bib37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.xkme.2023.100645_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.780122","article-title":"How advanced is our understanding of the role of intestinal barrier dysfunction in the pathogenesis of recurrent urinary tract infections","volume":"13","author":"Stepanova","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24354","article-title":"Exploring blood microbial communities and their influence on human cardiovascular disease","volume":"36","author":"Khan","year":"2022","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.xkme.2023.100645_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fcimb.2019.00148","article-title":"The healthy human blood microbiome: fact or fiction?","volume":"9","author":"Castillo","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/femsre\/fuv013","article-title":"The dormant blood microbiome in chronic, inflammatory diseases","volume":"39","author":"Potgieter","year":"2015","journal-title":"FEMS Microbiol Rev"},{"issue":"8","key":"10.1016\/j.xkme.2023.100645_bib42","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1128\/iai.64.8.3425-3428.1996","article-title":"Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells","volume":"64","author":"Visser","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.xkme.2023.100645_bib43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.ki.5001710","article-title":"Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells","volume":"70","author":"Haslinger-L\u00f6ffler","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2023.100645_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/microorganisms8020173","article-title":"Peritoneal microbiome in end-stage renal disease patients and the impact of peritoneal dialysis therapy","volume":"8","author":"Sim\u00f5es-Silva","year":"2020","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125162","article-title":"Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients","volume":"10","author":"Szeto","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2021.08.017","article-title":"Peritoneal effluent cell-free DNA sequencing in peritoneal dialysis patients with and without peritonitis","volume":"4","author":"Burnham","year":"2022","journal-title":"Kidney Med"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AEM.05605-11","article-title":"Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients","volume":"78","author":"Wang","year":"2012","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15650-9","article-title":"Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis","volume":"7","author":"Stadlbauer","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xkme.2023.100645_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.579386","article-title":"The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses","volume":"11","author":"Luo","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41430-022-01190-7","article-title":"Gut microbiota profile of patients on peritoneal dialysis: comparison with household contacts","volume":"77","author":"Teixeira","year":"2023","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.xkme.2023.100645_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0896860820976983","article-title":"Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients","volume":"41","author":"Jiang","year":"2021","journal-title":"Perit Dial Int"},{"issue":"9","key":"10.1016\/j.xkme.2023.100645_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184789","article-title":"Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial","volume":"12","author":"Yacoub","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12882-022-02704-y","article-title":"Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis","volume":"23","author":"Zhou","year":"2022","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12882-022-02762-2","article-title":"Correlation between intestinal flora disruption and protein\u2013energy wasting in patients with end-stage renal disease","volume":"23","author":"Hu","year":"2022","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.xkme.2023.100645_bib56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.xkme.2023.100645_bib57","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100645_bib58","first-page":"578","article-title":"The accumulation of gut microbiome\u2013derived indoxyl sulfate and p-cresyl sulfate in patients with end-stage renal disease","volume":"32","author":"Lin","year":"2022","journal-title":"J\u00a0Ren Nutr"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3747\/pdi.2012.00276","article-title":"Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function","volume":"34","author":"Viaene","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.xkme.2023.100645_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.639624","article-title":"Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients","volume":"12","author":"Bao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100645_bib61","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/toxins14040280","article-title":"Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings?","volume":"14","author":"El Chamieh","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12012-021-09718-2","article-title":"Indoxyl sulfate activates NLRP3 inflammasome to induce cardiac contractile dysfunction accompanied by myocardial fibrosis and hypertrophy","volume":"22","author":"Yamaguchi","year":"2022","journal-title":"Cardiovasc Toxicol"},{"issue":"2","key":"10.1016\/j.xkme.2023.100645_bib64","first-page":"71","article-title":"Cardiac and renal fibrosis and oxidative stress balance in lipopolysaccharide-induced inflammation in male rats","volume":"14","author":"Asgharzadeh","year":"2018","journal-title":"ARYA Atheroscler"},{"issue":"12","key":"10.1016\/j.xkme.2023.100645_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/toxins13120909","article-title":"Indoxyl sulfate contributes to mTORC1-induced renal fibrosis via the OAT\/NADPH oxidase\/ROS pathway","volume":"13","author":"Nakano","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.xkme.2023.100645_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.682482","article-title":"Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease","volume":"12","author":"Fang","year":"2021","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100645_bib67","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.nefroe.2018.11.010","article-title":"Contribution of uraemic toxins to the vascular fibrosis associated with chronic kidney disease","volume":"38","author":"Hatem-Vaquero","year":"2018","journal-title":"Nefrologia (Engl Ed)"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41598-020-79186-1","article-title":"Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis","volume":"11","author":"Alcalde-Est\u00e9vez","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100645_bib69","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xkme.2023.100645_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-981-15-2385-4_5","article-title":"Gut microbiota and lung injury","volume":"1238","author":"Tan","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xkme.2023.100645_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.trsl.2021.10.001","article-title":"Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients","volume":"240","author":"Zhang","year":"2022","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000441506","article-title":"Lipopolysaccharide induces chronic kidney injury and fibrosis through activation of mTOR signaling in macrophages","volume":"42","author":"Chen","year":"2015","journal-title":"Am J Nephrol"},{"issue":"21","key":"10.1016\/j.xkme.2023.100645_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111864","article-title":"The fibrotic effects of TMAO on human renal fibroblasts is mediated by NLRP3, caspase-1 and the PERK\/Akt\/mTOR pathway","volume":"22","author":"Kapetanaki","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib74","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"P-cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2023.100645_bib75","article-title":"P-cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes","volume":"4","author":"Han","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.xkme.2023.100645_bib76","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/biom12070867","article-title":"Vascular calcification and the gut and blood microbiome in chronic kidney disease patients on peritoneal dialysis: a pilot study","volume":"12","author":"Merino-Ribas","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.xkme.2023.100645_bib77","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2215\/CJN.02360213","article-title":"Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis","volume":"8","author":"Szeto","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100645_bib78","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1136\/gutjnl-2019-320118","article-title":"Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes","volume":"69","author":"Massier","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.xkme.2023.100645_bib79","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/emmm.201100159","article-title":"Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment","volume":"3","author":"Amar","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.xkme.2023.100645_bib80","first-page":"1","article-title":"The association between serum indoxyl sulfate, p-cresyl sulfate and cardiovascular risk factors in peritoneal dialysis patients","volume":"11","author":"Hiruy","year":"2021","journal-title":"J\u00a0Nephrol Ther"},{"issue":"7","key":"10.1016\/j.xkme.2023.100645_bib81","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.arcmed.2013.09.007","article-title":"Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up","volume":"44","author":"Lin","year":"2013","journal-title":"Arch Med Res"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2023.100645_bib82","first-page":"i498","article-title":"MO682: serum total indoxyl sulfate is associated with intraperitoneal inflammation and high peritonitis episodes in peritoneal dialysis patients","volume":"37","author":"Stepanova","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2023.100645_bib83","article-title":"The role of gut microbiota and microbiota-related serum metabolites in the progression of diabetic kidney disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.xkme.2023.100645_bib84","first-page":"20424","article-title":"Cytokine profiles in peritoneal dialysis effluent predicts the peritoneal solute transport rate in continuous ambulatory peritoneal dialysis patients","volume":"8","author":"Zhou","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"10.1016\/j.xkme.2023.100645_bib85","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/17.8.1480","article-title":"Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2023.100645_bib86","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1111\/jam.15504","article-title":"Balancing reactive oxygen species generation by rebooting gut microbiota","volume":"132","author":"Singh","year":"2022","journal-title":"J\u00a0Appl Microbiol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100645_bib87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3747\/pdi.2011.00032","article-title":"Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients","volume":"32","author":"Morinaga","year":"2012","journal-title":"Perit Dial Int"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:24:53Z","timestamp":1762910693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523000559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2590059523000559"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100645","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Gut-Peritoneum Axis in Peritoneal Dialysis and\u00a0Peritoneal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100645"}}